Friday, July 10, 2026

pharma · Cerebral adrenoleukodystrophy (cALD) · Adrenoleukodystrophy

Minoryx Therapeutics

News and analysis for Minoryx Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

ES HQ
2011 Founded
32 Employees
EMA registrant Type
Company details
Status
Public
HQ
ES
Founded
2011
Employees
32
Programs
4
Drugs
11
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Minoryx Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Minoryx Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Minoryx Therapeutics yet.

Back to company overview →